carbostyril has been researched along with Influenza, Human in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Delamaire, F; Gacouin, A; Guillot, P; Lesouhaitier, M; Maamar, A; Painvin, B; Piau, C; Reizine, F; TadiƩ, JM | 1 |
Ishikawa, T; Kamatari, YO; Makau, JN; Mizuta, S; Nishida, N; Otaki, H; Watanabe, K | 1 |
Boechat, Fda C; Brozeguini, L; Cunha, AC; de Souza, MC; Faro, LV; Ferreira, VF; Fintelman-Rodrigues, N; Forezi, Lda S; Marques, IP; Nogueira, CM; Riscado, CS; Sacramento, CQ; Sagrillo, FS; Santos-Filho, O; Souza, TM | 1 |
Niebyl, JR | 1 |
1 review(s) available for carbostyril and Influenza, Human
Article | Year |
---|---|
Antibiotics and other anti-infective agents in pregnancy and lactation.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Antiviral Agents; Drug Combinations; Female; Humans; Influenza, Human; Lactation; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Quinolones; Tetracyclines | 2003 |
3 other study(ies) available for carbostyril and Influenza, Human
Article | Year |
---|---|
Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; beta-Lactams; Community-Acquired Infections; Humans; Influenza, Human; Lactams; Legionnaires' Disease; Pneumonia, Mycoplasma; Quinolones; Retrospective Studies | 2023 |
A Quinolinone Compound Inhibiting the Oligomerization of Nucleoprotein of Influenza A Virus Prevents the Selection of Escape Mutants.
Topics: Animals; Cell Line, Tumor; Gene Expression Regulation, Viral; Humans; Influenza A virus; Influenza, Human; Mutation; Nucleocapsid Proteins; Protein Multimerization; Quinolones; Selection, Genetic; Transcription, Genetic | 2020 |
1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.
Topics: Antiviral Agents; Drug Design; Drug Resistance, Viral; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Molecular Docking Simulation; Neuraminidase; Oseltamivir; Quinolones; Triazoles | 2015 |